Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction (Q34409803)

2 August 2017

1 reference

title

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction (English)

1 reference

2 August 2017

0 references

0 references

Roques BP

1

1 reference

2 August 2017

Noble F

series ordinal

2

1 reference

2 August 2017

publication date

1 November 1996

1 reference

2 August 2017

published in

Neurochemical Research

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

1397-1410

1 reference

Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Opiate Receptor: Demonstration in Nervous Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Identification of two related pentapeptides from the brain with potent opiate agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Biological actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Endogenous opiates: 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

New peptide in the vertebrate CNS reacting with antigastrin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Two brain cholecystokinin receptors: implications for behavioral actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Expression cloning and characterization of the canine parietal cell gastrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

The role of CCK caerulein, and CCK antagonists in nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Effects of repeated treatment with haloperidol on rat striatal neutral endopeptidase, and on mu- and delta-opioid binding sites: comparison with chronic morphine and chronic kelatorphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Enzyme-resistant CCK analogs with high affinities for central receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Cholecystokinin octapeptide antagonized opioid analgesia mediated by mu- and kappa- but not delta-receptors in the spinal cord of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Role of spacer and address components in peptidomimetic .delta.-opioid receptor antagonists related to naltrindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Cholecystokinin and morphine analgesia: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Failure of cholecystokinin to precipitate withdrawal in morphine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Anatomically distinct opiate receptor fields mediate reward and physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Enkephalinase inhibition facilitates sexual behavior in the male rat but does not produce conditioned place preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Cholecystokinin-dopamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02532381

Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior.

21 January 2018

1 reference

12 December 2020

Cholecystokinin octapeptide reverses mu-opioid-receptor-mediated inhibition of calcium current in rat dorsal root ganglion neurons.

1 reference

12 December 2020

Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats

1 reference

12 December 2020

Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons

1 reference

12 December 2020

Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CA1 region of the rat hippocampal slice.

1 reference

12 December 2020

Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance

1 reference

12 December 2020

Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.

1 reference

12 December 2020

Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat

1 reference

12 December 2020

The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice

1 reference

12 December 2020

Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey

1 reference

12 December 2020

Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity

1 reference

12 December 2020

Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins

1 reference

12 December 2020

Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.

1 reference

12 December 2020

The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization

1 reference

12 December 2020

Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats

1 reference

12 December 2020

Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal caps

1 reference

12 December 2020

Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses

1 reference

12 December 2020

Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex

1 reference

12 December 2020

Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction

1 reference

12 December 2020

Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various br

1 reference

12 December 2020

Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine

1 reference

12 December 2020

Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.

1 reference

12 December 2020

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

12 December 2020

The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats

1 reference

12 December 2020

Potentiation of enkephalin action by peptidase inhibitors in rat locus ceruleus in vitro

1 reference

12 December 2020

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

1 reference

12 December 2020

Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors

1 reference

12 December 2020

Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology

1 reference

12 December 2020

The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats

1 reference

12 December 2020

Involvement of endogenous enkephalins in the mouse 'behavioral despair' test

1 reference

12 December 2020

In vivo release of CCK-8 from the dorsal horn of the rat: Inhibition by DAGOL

1 reference

12 December 2020

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist

1 reference

12 December 2020

Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin

1 reference

12 December 2020

Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats

1 reference

12 December 2020

Role of different brain structures in the expression of the physical morphine withdrawal syndrome

1 reference

12 December 2020

Physiological role of endogenous peptide effectors studied with peptidase inhibitors.

1 reference

12 December 2020

Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine

1 reference

12 December 2020

Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02532381

1 reference

Dimensions Publication ID

2 August 2017

1020167229

0 references

1 reference